Business Wire

Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse

27.6.2025 22:44:00 CEST | Business Wire | Press Release

Share

Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed.

Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further accelerate the journey towards modernizing enterprise platforms for its customers.

Altimetrik is among the most evolved digital services providers with advanced data and digital engineering capabilities, a bite sized approach that creates high ROI client outcomes and exceptional track record of data and AI led deployments. Altimetrik will additionally leverage SLK’s deep customer relationships, global operational footprint and complementary leadership talent to further deliver innovation-led value creation for customers.

“In today’s world, AI, and especially Generative AI and Machine Learning, is the engine that is driving true business value,” said Raj Sundaresan, CEO of Altimetrik. “To enable an AI-First business a robust data cloud infrastructure that is grounded in product and platform engineering rigor is crucial. Our investment in SLK reflects our intention to deepen our commitment to customers who are looking for digital, AI-driven solutions that enable business value creation at unparalleled speed and scale. We are incredibly excited and look forward to welcoming SLK Software to the Altimetrik family.”

“This is not a traditional integration. It is a strategic acceleration,” said Parth Amin, Founder & Chairman of SLK Software. “In Altimetrik, we’ve found a partner who shares our values of customer intimacy, people centricity, and a passion for innovation and agility. Together we will unlock greater capabilities for our clients while preserving the speed and responsiveness they trust us for.”

Upon the closing of the transaction, the combined entity will serve a global customer base of over 150 businesses that include Fortune 500 companies and some of the most innovative tech enterprises. It will also enable a partnership network that includes era-defining pioneers such as OpenAI, Amazon Web Services, Snowflake, and Databricks. Together, the business will employ over 10,000 professionals around the world to support customers who are in their digital transformation journey and are looking for innovative solutions to modernize legacy systems through leveraging data and AI, while ensuring world-class governance, compliance, and platform security. This includes organizations across diverse industries, from Financial Services & Payments to Pharma and Lifesciences, to Technology and Manufacturing.

“Altimetrik and SLK coming together is a strategic leap for the industry,” said Puneet Bhatia, Co-Managing Partner and Country Head, India of TPG Capital Asia and Board Member at Altimetrik. “This combination creates an AI-first digital engineering platform with the scale, leadership, and execution muscle to deliver meaningful outcomes across industries. With TPG’s track record and experience in supporting enterprise tech businesses, we are proud to be able to support this next phase of growth and value creation.”

“This acquisition underscores TPG’s investment thesis in technology services, which is indexed on backing strategic technology providers that are leading the data and AI transformation journey for customers, with differentiated business, pricing and delivery models,” said Vivek Mohan, Business Unit Partner at TPG Capital Asia and Board Member at Altimetrik.

Highlighting the breadth and depth of the combined business, Raj Vattikuti, Board Member and Founder of Altimetrik said, “Beyond combining capabilities, bringing together the two businesses is about scaling what we do best: solving real business problems with precision and speed. With SLK, we are expanding our ability to bring industry context, simplify complexity, and deliver AI-native transformation.”

Ajay Kumar, CEO of SLK Software added, “SLK’s customer-first approach has led to building offerings powered by AI to deliver outstanding results for our clients. As a combined entity, SLK and Altimetrik are now set to unlock exceptional value and drive measurable impact at scale for our clients.”

Avendus Capital acted as the exclusive financial advisor to SLK Software. EY acted as the exclusive financial advisor to Altimetrik and TPG.

About Altimetrik

Altimetrik is a pure-play AI, Data, and Digital business services company. We focus on delivering business outcomes with an incremental, product-oriented approach. Our industry-first, proven digital business methodology provides a blueprint to develop, scale, and launch new products to market faster. Our team of 6,000+ practitioners with software, data, and cloud skills builds an agile engineering culture of collaboration and innovation that modernizes technology and builds new business models in bite-sized increments. As a strategic partner and catalyst, Altimetrik quickly delivers results without disruption. Recognized as a Major Contender in Everest Group’s BFSI IT Services Specialists PEAK Matrix® Assessment 2025 and a Product Challenger in ISG Provider Lens™ 2024 for Advanced Analytics and AI Services, Altimetrik continues to lead the way in delivering cutting-edge digital transformation. Learn more at altimetrik.com.

About SLK Software

SLK Software is a global technology services provider focused on bringing AI, intelligent automation, and analytics together to create leading-edge technology solutions for our customers through a culture of partnership with them, led by an evolutionary mindset. For 25 years, we have helped organizations across diverse industries — insurance providers, financial service organizations, investment management companies, and manufacturers — reimagine their business and solve their present and future needs. Certified as a Great Place To Work®, we encourage an approach of constructively challenging the status quo in all that we do to enable peak business performance for our customers and for ourselves, through disruptive technologies, applied innovation, and purposeful automation. Find out how we help leading organizations reimagine their business at www.slksoftware.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250627894293/en/

Contacts

Media Contacts:

Altimetrik
Gurvinder Singh Sahni
GSahni@altimetrik.com

Matt McLoughlin
Gregory FCA on behalf of Altimetrik
altimetrik@GregoryFCA.com - altimetrik@gregoryfca.com
+1 610-228-2123

SLK Software
Mohsina Faiz
mohsina.faiz@slksoftware.com
+91 8805008702

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye